10.24335/L17505
RoyaltyStat
Sale and transfer of all capital stock of DioGenix Inc., including its molecular diagnostic business unit directed to autoimmune neurodegenerative conditions, with royalty due for products for non-invasive molecular diagnosis of multiple sclerosis in humans.
RoyaltyStat
2008